Magnesium, hyperactivity and autism in children

Magnesium in the Central Nervous System

Volumn , Issue , 2011, Pages 283-302

  Mousain Bosc, Marianne ^a   Siatka, Christian ^a   Bali, Jean Pierre ^b  

^a Ecole de l’ADN Museum d’Histoire Naturelle de Nîmes ^*  (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876273626     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/UPO9780987073051.022     Document Type: Chapter

References (78)

1. Adams JB, Holloway C (2004) Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder. J Altern Complement Med 10:1033–9.
2. Alexander RT, Hoenderop JG, Bindels RJ (2008) Molecular determinants of magnesium homeostasis: insights from human disease. J Am Soc Nephrol 19:1451–8.
3. Altura BM, Altura BT (1978) Magnesium and vascular tone and reactivity. Blood Vessels 15:5–16.
4. Association AP. (1994). Diagnostic and Statistical Manual of Mental Disorders DSM–IV–TR Fourth Edition: American Psychiatric Association.
5. Basso LE, Ubbink JB, Delport R (2000) Erythrocyte magnesium concentration as an index of magnesium status: a perspective from a magnesium supplementation study. Clin Chim Acta 291:1–8.
6. Biederman J, Faraone SV, Spencer TJ, Mick E, Monuteaux MC, Aleardi M (2006) Functional impairments in adults with self–reports of diagnosed ADHD: A controlled study of 1001 adults in the community. J Clin Psychiatry 67:524–40.
7. Billard JM (2006) Ageing, hippocampal synaptic activity and magnesium. Magnes Res 19:199–215.
8. Borella P, Ambrosini G, Concari M, Bargellini A (1993) Is magnesium content in erythrocytes suitable for evaluating cation retention after oral physiological supplementation in marginally magnesium–deficient subjects? Magnes Res 6:149–53.
9. Burn R (2009) The Effect of Magnesium Deficiency on Brain Function: Autism Spectrum Disorder, Neurology, Genetics and Remedial Solutions. The Autism Centre, Carmarthenshire, UK.
10. Chakraborti S, Chakraborti T, Mandal M, Mandal A, Das S, Ghosh S (2002) Protective role of magnesium in cardiovascular diseases: a review. Mol Cell Biochem 238:163–79.
11. Chubanov V, Waldegger S, Mederosy Schnitzler M, Vitzthum H, Sassen MC, Seyberth HW, Konrad M, Gudermann T (2004) Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci USA 101:2894–9.
12. Colter AL, Cutler C, Meckling KA (2008) Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case–control study. Nutr J 7:8.
13. De Franceschi L, Bachir D, Galacteros F, Tchernia G, Cynober T, Neuberg D, Beuzard Y, Brugnara C (2000) Oral magnesium pidolate: effects of long–term administration in patients with sickle cell disease. Br J Haematol 108:284–9.
14. De Jesus Moreno, Moreno M (2003) Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double–blind, randomized, placebo–controlled trial. Clin Ther 25:178–93.
15. Demougeot C, Bobillier-Chaumont S, Mossiat C, Marie C, Berthelot A (2004) Effect of diets with different magnesium content in ischemic stroke rats. Neurosci Lett 362:17–20.
16. DeRose VJ (2007) Sensing cellular magnesium with RNA. Nat Chem Biol 3:693–4.
17. Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S, Bear MF (2007) Correction of fragile X syndrome in mice. Neuron 56:955–62.
18. Doyle LW, Crowther CA, Middleton P, Marret S (2007) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev: CD004661.
19. Ebel H, Kreis R, Gunther T (2004) Regulation of Na+/Mg2+ antiport in rat erythrocytes. Biochim Biophys Acta 1664:150–60.
20. Ebel H, Gunther T (2005) Na+/Mg2+ antiport in erythrocytes of spontaneously hypertensive rats: role of Mg2+ in the pathogenesis of hypertension. Magnes Res 18:175–85.
21. Feillet-Coudray C, Coudray C, Wolf FI, Henrotte JG, Rayssiguier Y, Mazur A (2004) Magnesium metabolism in mice selected for high and low erythrocyte magnesium levels. Metabolism 53:660–5.
22. Feillet-Coudray C, Trzeciakiewicz A, Coudray C, Rambeau M, Chanson A, Rayssiguier Y, Opolski A, Wolf FI, Mazur A (2006) Erythrocyte magnesium fluxes in mice with nutritionally and genetically low magnesium status. Eur J Nutr 45:171–7.
23. Fergusson JW RJ, O’Laughlin JW, Banks CV (1964) Simultaneous spectrophotometric determination of calcium and magnesium with chlorophosphonazo III. Anal Chem 36:796–99.
24. Findling RL, Maxwell K, Scotese–Wojtila L, Huang J, Yamashita T, Wiznitzer M (1997) High–dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a doubleblind, placebo–controlled study. J Autism Dev Disord 27:467–78.
25. Folsom AR, Hong CP (2006) Magnesium intake and reduced risk of colon cancer in a prospective study of women. Am J Epidemiol 163:232–5.
26. Gervais H, Belin P, Boddaert N, Leboyer M, Coez A, Sfaello I, Barthelemy C, Brunelle F, Samson Y, Zilbovicius M (2004) Abnormal cortical voice processing in autism. Nat Neurosci 7:801–2.
27. Gonon F (2009) The dopaminergic hypothesis of attention–deficit/hyperactivity disorder needs reexamining. Trends Neurosci 32:2–8.
28. Gould MS, Walsh BT, Munfakh JL, Kleinman M, Duan N, Olfson M, Greenhill L, Cooper T (2009) Sudden death and use of stimulant medications in youths. Am J Psychiatry 166:992–1001.
29. Gunther T (2007) Na+/Mg2+ antiport in non–erythrocyte vertebrate cells. Magnes Res 20:89–99.
30. Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S (2007) Inhibition of p21–activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA 104:11489–94.
31. Heath DL, Vink R (1998) Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: a comparative phosphorus NMR study. J Neurotrauma 15:183–9.
32. Helpern JA, Vande Linde AM, Welch KM, Levine SR, Schultz LR, Ordidge RJ, Halvorson HR, Hugg JW (1993) Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia. Neurology 43:1577–81.
33. Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E (2006) Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR–dependent long–term depression. Neuron 51:441–54.
34. Iotti S, Malucelli E (2008) In vivo assessment of Mg2+ in human brain and skeletal muscle by 31P–MRS. Magnes Res 21:157–62.
35. Jordt SE, Ehrlich BE (2007) TRP channels in disease. Subcell Biochem 45:253–71.
36. Kidd PM (2002) Autism, an extreme challenge to integrative medicine. Part 2: medical management. Altern Med Rev 7:472–99.
37. Kozielec T, Starobrat-Hermelin B (1997) Assessment of magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res 10:143–8.
38. Kuriyama S, Kamiyama M, Watanabe M, Tamahashi S, Muraguchi I, Watanabe T, Hozawa A, Ohkubo T, Nishino Y, Tsubono Y, Tsuji I, Hisamichi S (2002) Pyridoxine treatment in a subgroup of children with pervasive developmental disorders. Dev Med Child Neurol 44:284–6.
39. Lelord G, Callaway E, Muh JP (1982) Clinical and biological effects of high doses of vitamin B6 and magnesium on autistic children. Acta Vitaminol Enzymol 4:27–44.
40. Liebscher D H LDE (2004) About the misdiagnosis of magnesium deficiency. J Am Coll Nutr 23:730S–1S.
41. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R (2004) Magnesium and experimental vasospasm. J Neurosurg 100:106–10.
42. Martin H, Staedtler F, Lamboley C, Adrian M, Schumacher MM, Chibout SD, Laurant P, Richert L, Berthelot A (2007) Effects of long–term dietary intake of magnesium on rat liver transcriptome. Magnes Res 20:259–65.
43. Martineau J, Barthelemy C, Cheliakine C, Lelord G (1988) Brief report: an open middle–term study of combined vitamin B6–magnesium in a subgroup of autistic children selected on their sensitivity to this treatment. J Autism Dev Disord 18:435–47.
44. Montell C (2003) Mg2+ homeostasis: the Mg2+nificent TRPM chanzymes. Curr Biol 13:R799–801.
45. Montell C (2005) The TRP superfamily of cation channels. Sci STKE 2005:re3.
46. Mousain-Bosc M, Roche M, Rapin J, Bali JP (2004) Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr 23:545S–8S.
47. Mousain-Bosc M, Roche M, Polge A, Pradal–Prat D, Rapin J, Bali JP (2006) Improvement of neurobehavioral disorders in children supplemented with magnesiumvitamin B6. II. Pervasive developmental disorder–autism. Magnes Res 19:53–62.
48. Murza KA, Pavelko SL, Malani MD, Nye C (2010) Vitamin B 6–magnesium treatment for autism: the current status of the research. Magnes Res 23:115–7.
49. Nemoto T, Matsuzaki H, Uehara M, Suzuki K (2006) Magnesium–deficient diet–induced reduction in protein utilization in rats is reversed by dietary magnesium supplementation. Magnes Res 19:19–27.
50. Nilius B (2007) TRP channels in disease. Biochim Biophys Acta 1772:805–12.
51. Nilius B, Owsianik G, Voets T (2008) Transient receptor potential channels meet phosphoinositides. EMBO J 27:2809–16.
52. Nye C, Brice A (2005) Combined vitamin B6–magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev: CD003497.
53. Ozgo M, Bayle D, Zimowska W, Mazur A (2007) Effect of a low magnesium diet on magnesium status and gene expression in the kidneys of mice selected for high and low magnesium erythrocyte levels. Magnes Res 20:148–53.
54. Picado MJ, de la Sierra A, Aguilera MT, Coca A, Urbano-Marquez A (1994) Increased activity of the Mg2+/Na+ exchanger in red blood cells from essential hypertensive patients. Hypertension 23:987–91.
55. Rimland B, Callaway E, Dreyfus P (1978) The effect of high doses of vitamin B6 on autistic children: a doubleblind crossover study. Am J Psychiatry 135:472–5.
56. Sanjad SA, Hariri A, Habbal ZM, Lifton RP (2007) A novel PCLN–1 gene mutation in familial hypomagnesemia with hypercalciuria and atypical phenotype. Pediatr Nephrol 22:503–8.
57. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31:166–70.
58. Schlingmann KP, Gudermann T (2005) A critical role of TRPM channel–kinase for human magnesium transport. J Physiol 566:301–8.
59. Schmidt CJ, Taylor VL (1988) Release of [3H]norepinephrine from rat hippocampal slices by Nmethyl–D–aspartate: comparison of the inhibitory effects of Mg2+ and MK–801. Eur J Pharmacol 156:111–20.
60. Schmidt ME, Kruesi MJ, Elia J, Borcherding BG, Elin RJ, Hosseini JM, McFarlin KE, Hamburger S (1994) Effect of dextroamphetamine and methylphenidate on calcium and magnesium concentration in hyperactive boys. Psychiatry Res 54:199–210.
61. Schmitz C, Perraud AL, Johnson CO, Inabe K, Smith MK, Penner R, Kurosaki T, Fleig A, Scharenberg AM (2003) Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 114:191–200.
62. Shalev H, Phillip M, Galil A, Carmi R, Landau D (1998) Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child 78:127–30.
63. Slutsky I, Abumaria N, Wu LJ, Huang C, Zhang L, Li B, Zhao X, Govindarajan A, Zhao MG, Zhuo M, Tonegawa S, Liu G (2010) Enhancement of learning and memory by elevating brain magnesium. Neuron 65:165–77.
64. Spencer TJ, Biederman, J., Wilens, T.E. & Faraone, S.V (2002) Overview and neurobiology of attentiondeficit/hyperactivity disorder. J Clin Psychiatry 63:3–9.
65. Starobrat-Hermelin B, Kozielec T (1997) The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD). Positive response to magnesium oral loading test. Magnes Res 10:149–56.
66. Takaya J, Yamato F, Kaneko K (2006) Possible relationship between low birth weight and magnesium status: from the standpoint of –fetal origin— hypothesis. Magnes Res 19:63–9.
67. Tolbert L, Haigler T, Waits MM, Dennis T (1993) Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium. J Autism Dev Disord 23:193–9.
68. Trapani V, Farruggia G, Marraccini C, Iotti S, Cittadini A, Wolf FI (2010) Intracellular magnesium detection: imaging a brighter future. Analyst 135:1855–66.
69. Van der Wiijst J, Hodenrop, JGJ, Bindels, RJM (2009) Epithelial Mg2+ channel TRPM6: insight into the molecular regulation. Magnes Res 22:127–32.
70. Vink R (2001) Magnesium in traumatic brain injury: past findings and future directions, In: Advances in Magnesium Research: Nutrition and Health/Y. Rayssiguier, A. Mazur, J. Durlach (eds.) John Libbey and Company, London, pp. 405–12.
71. Vink R, Cook NL, van den Heuvel C (2009) Magnesium in acute and chronic brain injury: an update. Magnes Res 22:158S–62S.
72. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, Bindels RJ, Hoenderop JG (2004) TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem 279:19–25.
73. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, Borochowitz Z, Boettger MB, Beck GE, Englehardt RK, Carmi R, Sheffield VC (2002) Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 31:171–4.
74. Weisman-Shomer P, Cohen E, Fry M (2002) Distinct domains in the CArG–box binding factor A destabilize tetraplex forms of the fragile X expanded sequence d(CGG)n. Nucleic Acids Res 30:3672–81.
75. Wiesner GL, Cassidy SB, Grimes SJ, Matthews AL, Acheson LS (2004) Clinical consult: developmental delay/fragile X syndrome. Prim Care 31:621–5.
76. Wolf FI, Trapani V, Cittadini A (2008) Magnesium and the control of cell proliferation: looking for a needle in a haystack. Magnes Res 21:83–91.
77. Wolf FI, Trapani V, Cittadini A, Maier JA (2009) Hypomagnesaemia in oncologic patients: to treat or not to treat? Magnes Res 22:5–9.
78. Zilbovicius M, Boddaert N, Belin P, Poline JB, Remy P, Mangin JF, Thivard L, Barthelemy C, Samson Y (2000) Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. Am J Psychiatry 157:1988–93.